Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Phenylephrine Hydrochloride Market

Phenylephrine Hydrochloride Market Trends

Report ID: GMI6848
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Phenylephrine Hydrochloride Market Trends

The applications of Phenylephrine HCL (Phenylephrine Hydrochloride) API have been diversifying, extending beyond its conventional role as a decongestant. In addition to its well-established use in decongestant medications for nasal relief, Phenylephrine HCL has found increasing relevance in various medical and non-medical domains. Beyond respiratory health, Phenylephrine HCL has also made inroads into ophthalmic applications. It is utilized in ophthalmic solutions as a mydriatic agent, facilitating pupil dilation during eye examinations and surgeries. This function enhances the visibility of the eye's internal structures, aiding medical professionals in diagnostics and surgical procedures. Thus, wide number of applications of phenylephrine hydrochloride drive the market growth

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Phenylephrine hydrochloride (HCL) market size was USD 777.6 million in 2022 and may reach USD 1.6 billion by 2032 driven by the consistent demand for decongestant medications to counter respiratory ailments.

The nasal decongestion application segment held 29.5% share of the phenylephrine hydrochloride industry in 2022 due to the surging need for effectively reducing the swelling and congestion in common cold, allergies, sinusitis, and hay fever.

North America recorded 38.9% share of the global phenylephrine hydrochloride market in 2022 owing to higher importance in the pharmaceutical sector, primarily due to its key role in the production of nasal decongestant medications.

Some of the well-known phenylephrine HCL market players are Cornileus Pharmaceuticals (P) Ltd, Aarti Pharmalabs Limited, Ralington Pharma, SNA Healthcare Private Limited, Shenzhen Oriental Pharmaceutical Co. Ltd., Unichem Laboratories Ltd., and Kavya Pharma.